Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.
Lin RK, Su CM, Lin SY, Thi Anh Thu L, Liew PL, Chen JY, Tzeng HE, Liu YR, Chang TH, Lee CY, et al. Mol Med. 2022 Jun 17; 28(1):67. Epub 2022 Jun 17.